United States· US:50881-034_3040fced-394e-48d8-b875-6b7a362eb95d
NIKTIMVO
A axatilimab product containing axatilimab, registered in United States by Incyte Corporation.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- AXATILIMAB
- Manufacturer
- Incyte Corporation
- Country
- United States (US)
- ATC code
- L04AG19
- ATC class
- Axatilimab
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1150881-034-12
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L04AG19
Axatilimab, as other registers publish it.
- United StatesNIKTIMVOIncyte Corporation
- United StatesNIKTIMVOIncyte Corporation
- United StatesNIKTIMVOIncyte Corporation
- United StatesNIKTIMVOIncyte Corporation
- United StatesNIKTIMVOIncyte Corporation
- United StatesNIKTIMVOIncyte Corporation
- United StatesNIKTIMVOIncyte Corporation
- United StatesNIKTIMVOIncyte Corporation
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bc36df4f-f51a-4682-a94e-558fdb97f6a3 GET /v1/drugs/bc36df4f-f51a-4682-a94e-558fdb97f6a3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "9",
"substance": "AXATILIMAB",
"productndc": "50881-034",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/.18mL",
"application_number": "BLA761411",
"marketing_category": "BLA"
}See everything about axatilimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.